Anthony A. Amato

MedicineBiochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile

0.104Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Item selection for the development and validation of a revised classification criteria for adult and juvenile idiopathic inflammatory myopathies: MyoROC project

Seminars in Arthritis and Rheumatism(2025)10.1016/j.semarthrit.2025.152822

Top 78%

0.104DataRank

Top 78%1 citations

Rachel Zeng, Stefanie Glaubitz, Matteo Bottai, Anthony A. Amato, Lorenzo Cavagna +19 more

Papers

Driven by 13 papers — median percentile 22. Top paper: “Inclusion body myositis: Clinical and pathological boundaries”.

Inclusion body myositis: Clinical and pathological boundaries

Annals of Neurology(1996)10.1002/ana.410400407

N/A

13.7DataRank · unranked

195 citations

Gary S. Gronseth, Carlayne E. Jackson, Gil I. Wolfe, Jon S. Katz, Wilson W. Bryan +2 more

Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis

Neurology(2021)10.1212/wnl.0000000000013121

N/A

4.5DataRank · unranked

137 citations

Christopher S. Coffey, Jonathan M. Goldstein, Mazen M. Dimachkie, Michael Benatar, John T. Kissel +25 more

Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial

The Lancet Neurology(2023)10.1016/s1474-4422(23)00275-2

N/A

0.867DataRank · unranked

34 citations

Michael McDermott, Thomas Blaettler, Claus Sundgreen, Anthony A. Amato, Emma Ciafaloni +74 more

Frequency and type of cancers in myotonic dystrophy: A retrospective cross‐sectional study

Muscle & Nerve(2023)10.1002/mus.27801

N/A

0.856DataRank · unranked

13 citations

Kathy Chuang, William S. David, Anthony A. Amato, Paloma González-Pérez, Eleonora S. D’Ambrosio

Inflammatory Myopathies

Continuum(2013)10.1212/01.con.0000440662.26427.bd

N/A

0.515DataRank · unranked

30 citations

Steven A. Greenberg, Anthony A. Amato

Item selection for the development and validation of a revised classification criteria for adult and juvenile idiopathic inflammatory myopathies: MyoROC project

Seminars in Arthritis and Rheumatism(2025)10.1016/j.semarthrit.2025.152822

Top 78%

0.104DataRank

Top 78%1 citations

Rachel Zeng, Stefanie Glaubitz, Matteo Bottai, Anthony A. Amato, Lorenzo Cavagna +19 more

International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative

Nature Reviews Rheumatology(2023)10.1038/s41584-023-01045-w

N/A

0DataRank · unranked

142 citations

Jeffrey P. Callen, Hector Chinoy, Leland W.K. Chung, David Fiorentino, Patrick Gordon +74 more

Episodic Ataxia Type 1: Natural History and Effect on Quality of Life

The Cerebellum(2022)10.1007/s12311-021-01360-6

N/A

0DataRank · unranked

2 citations

Robert C. Griggs, Brian N. Bundy, Joanna C. Jen, Robert W. Baloh, Michael G. Hanna +22 more

Parent-of-Origin Effect on the Age at Symptom Onset in Myotonic Dystrophy Type 2

Neurology Genetics(2023)10.1212/nxg.0000000000200073

N/A

0DataRank · unranked

8 citations

Eleonora S. D’Ambrosio, Vincent Picher‐Martel, Kathy Chuang, William S. David, Anthony A. Amato +1 more

Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles

Lara D. Veeken(2023)10.1093/rheumatology/kead110

N/A

0DataRank · unranked

7 citations

Hanna Kim, Christian Douglas, Brian Erman, Jesse Wilkerson, John A. McGrath +17 more

Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis

Neurology(2021)10.1212/wnl.0000000000011626

N/A

0DataRank · unranked

37 citations

Michael G. Hanna, Pedro Machado, Umesh A. Badrising, Hector Chinoy, Olivier Benvéniste +93 more

Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial

The Lancet Rheumatology(2023)10.1016/s2665-9913(23)00003-6

N/A

0DataRank · unranked

55 citations

Anthony A. Amato, Mazen M. Dimachkie, Hector Chinoy, Yessar Hussain, James B Lilleker +43 more

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

The Lancet Neurology(2020)10.1016/s1474-4422(20)30413-0

N/A

0DataRank · unranked

121 citations

Jeffrey T. Guptill, Saiju Jacob, Yingkai Li, Maria Elena Farrugia, Amanda C. Guidon +40 more

Anthony A. Amato

Indexed papers

Top data-sharing exemplar

Papers